Attend the 5th Liquid Biopsy for Precision Oncology Summit East Coast
Join senior biopharma and diagnostic leaders at the forefront of liquid biopsy innovation at the 5th Liquid Biopsy for Precision Oncology Summit East Coast in the united goal of redefining how ctDNA, MRD and multi-omic profiling are transforming oncology drug development.
You can expect to participate in regulatory-ready discussions on MRD as an endpoint, hear cutting-edge data on molecular response and durability, and gain practical insights into companion diagnostics, dose optimization and scalable deployment.
Through focused presentations, panels, interactive roundtables and high-value networking, acquire the evidence, partnerships and strategic clarity needed to move from exploratory signal to confident, decision-grade precision oncology.
What's New for 2026?
84% Brand-New Speaker Faculty
Hear fresh data, industry insights and new perspectives from leaders spanning pharma, biotech and diagnostics, not available anywhere else.
More Pharma Representation Than Ever
As ctDNA and MRD become embedded across clinical development, gain direct insight into how leading pharma teams are deploying, optimizing and scaling liquid biopsy strategies in real-world trials.
Dedicated One-to-One Partnering Sessions
No more choosing between content and connections. With additional scheduled partnering time, you are guaranteed to meet innovative solution providers, without compromising on key sessions.
New Data, New Discussions, New Decision-Makers
Engage with the people actively shaping precision oncology strategy today. Understand where integration truly accelerates development, and how to make complex assays decision-grade at scale.
Expanded Focus on Multi-Omic & Integrated Diagnostics
Move beyond mutation-only profiling and explore how methylation, multi-omic integration and AI-enabled workflows are generating earlier, more confident trial signals.
Extended Formal & Informal
Networking
Spend over 10 hours connecting with leading pharma and diagnostic experts, forging new relationships and strengthening existing ones through structured partnering sessions and informal discussions.
Delve into the Brand-New Agenda
- Find the full speaker faculty, featuring senior leaders from Pfizer, AbbVie, Takeda, AstraZeneca, GSK and more
- Plan your 2026 experience, identify the sessions you cannot miss and map the partners to meet
- Gain exclusive insights into MRD as a regulatory endpoint, ctDNA-driven dose optimization, and AI-integration in precision oncology pipelines
- Unpack the complete details of our in-depth Pre-Conference Engager Sessions and register your interest before spots are filled
Convene with Pharma Giants Including
Speaker Faculty Composition
Speaker Faculty Account Type
*Based on the Speaker Faculty at the 5th Liquid Biopsy for Precision Oncology Summit East Coast
Speaker Faculty Seniority
Explore the New Agenda
Discover the latest breakthroughs in ctDNA, MRD, methylation and multi-omic profiling through a focused program of expert presentations, interactive roundtables and strategic panel discussions driving precision oncology forward.
Stand at the Forefront of Liquid Biopsy Innovation
Position your solutions alongside leading diagnostic and technology providers to ensure your brand is central to the conversations shaping the next generation of oncology drug development.
Join Senior Biopharma & Diagnostic Leaders
Engage with decision-makers across translational medicine, precision oncology and clinical development, and build high-value connections during dedicated networking sessions designed to foster collaborations.